Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.

MLA

Pollard, Harvey B., et al. “Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-Refractory Prostate Cancer.” In Vivo (Athens, Greece), vol. 24, no. 3, May 2010, pp. 249–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20554995&authtype=sso&custid=ns315887.

APA

Pollard, H. B., Levine, M. A., Eidelman, O., & Pollard, M. (2010). Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer. In Vivo (Athens, Greece), 24(3), 249–255.

Chicago

Pollard, Harvey B, Mark A Levine, Ofer Eidelman, and Morris Pollard. 2010. “Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-Refractory Prostate Cancer.” In Vivo (Athens, Greece) 24 (3): 249–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20554995&authtype=sso&custid=ns315887.